Lyme Disease Biobank Foundation

Analysis

Lyme Disease Biobank Foundation is a registered charity in United States, based in Portland, OR. It received its IRS tax-exemption ruling in August 2016, 10 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a supporting organisation (type i) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Lyme Disease Biobank Foundation reported income of $829k and spending of $729k, spending 88% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $875k to $829k (-5.3%), an average of -1.3% a year. The sharpest change came in the year to December 2022, when income rose by 38%. Over the whole period it spent 104% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Lyme Disease Biobank Foundation sits at the 62nd percentile: it is larger than about 62% of them. Against every charity in United States with reported income it ranks in the 77th percentile, and in the 78th percentile within OR. Charities of a similar size with the same main cause include United Cerebral Palsy Association of Michigan ($829k), Thyca Thyroid Cancer Survivors Association Inc ($830k) and Western Society of Allergy Asthma & ($829k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 98% and program service revenue 1.9% of the total. Compensation of current officers, directors and key employees was $164k (23% of expenses). At year end it held assets of $77k against liabilities of $63k, net assets of $14k.